Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

This 29-year heart study tracked what happens after smokers quit

20

Aug 2026

This 29-year heart study tracked what happens after smokers quit

Long-term data from the Copenhagen City Heart Study linked both current and former smoking with a higher risk of sudden cardiac death, with risk rising alongside cumulative smoking exposure. Among former smokers, risk generally declined with longer time since quitting and approached that of never smokers only after prolonged abstinence.

More coffee, higher testosterone? This study found a more complicated picture

20

Aug 2026

More coffee, higher testosterone? This study found a more complicated picture

Higher habitual coffee intake was associated with a leaner body composition, lower circulating branched-chain amino acids, and distinct cardiometabolic patterns in 2,264 middle-aged Finnish adults. Hormonal associations differed by sex, with broader testosterone- and SHBG-related patterns in men and more limited SHBG-related changes in women.

First 24 hours shape the body's antiviral defense response

19

Aug 2026

First 24 hours shape the body's antiviral defense response

Age, genetics and lifestyle are known to influence how people respond to viral infections. Scientists also know that differences in immune response play an important role, but exactly how these factors shape the course of an infection has remained unclear.

New studies reveal hidden control hub for MYC-driven cancers

19

Aug 2026

New studies reveal hidden control hub for MYC-driven cancers

In a rare pair of papers published back-to-back in the journal Genes & Development, research teams led by senior author Anindya Bagchi, PhD, associate professor in the Cancer Genome and Epigenetics Program at Sanford Burnham Prebys Medical Discovery Institute, establish a unified framework that governs one of cancer's most powerful master regulators.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.